The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Zoledronic acid effect on circulating RANK/RANK-l/OPG axis in cancer patients.
Toni Ibrahim
No relevant relationships to disclose
Laura Mercatali
No relevant relationships to disclose
Marianna Ricci
No relevant relationships to disclose
Emanuela Scarpi
No relevant relationships to disclose
Francesca Fabbri
No relevant relationships to disclose
Chiara Liverani
No relevant relationships to disclose
Stefania Vittoria, Luisa Nicoletti
No relevant relationships to disclose
Rossana Ricci
No relevant relationships to disclose
Patrizia Serra
No relevant relationships to disclose
Dino Amadori
No relevant relationships to disclose